Leserbrief
Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!
Clinical Obesity · 2026-06 · 16 (3)
DOI: 10.1111/cob.70078 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Obesity, online erschienen am 03.05.2026. Verfasst von Giovanna Muscogiuri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University Federico II, Naples, Italy. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine and Surgery, University Federico II, Naples, Italy.
Zitieren
APA
Muscogiuri, G., & Colao, A. (2026). Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!. Clinical Obesity, 16(3). https://doi.org/10.1111/cob.70078
Vancouver
Muscogiuri G, Colao A. Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!. Clinical Obesity. 2026;16(3). doi:10.1111/cob.70078
BibTeX
@article{Muscogiuri2026,
author = {Muscogiuri, Giovanna and Colao, Annamaria},
title = {Use of GLP ‐1 Analogues in Obesity and the Risk of Non‐Arteritic Ischaemic Optic Neuropathy: Let's Clarify!},
journal = {Clinical Obesity},
year = {2026},
volume = {16},
number = {3},
doi = {10.1111/cob.70078}
}
EUVIMED